Tag: Steel Therapeutics
Steel Therapeutics completes first steps for Fizurex FDA approval
North Liberty-based Steel Therapeutics, an early stage pharmarceutical company focused on increasing access to compounded drug therapies, announced Sept. 12 it has completed pre-investigational...
Steel Therapeutics announces $1.5M in funding, addition of veteran Pharmaceutical Executive to board
Steel Therapeutics, Inc., an early stage pharmaceutical company focused on increasing access to compounded drug therapies, announced today that it has closed on $1.5M...
Steel Therapeutics successfully closes its seed financing round
Steel Therapeutics — an early stage pharmaceutical company focused on increasing access to compounded drug therapies — announced Tuesday that it had closed its...